Steris Cash Flow Statement
STE / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | $614.6M | $378.2M | $107.0M | $243.9M | $397.4M | $407.7M | $303.7M | $64.5M | $110.0M |
| Depreciation & Amortization | - | $476.2M | $565.2M | $552.9M | $553.1M | $219.2M | $197.2M | $225.9M | - | $188.1M |
| Operating Cash Flow | - | $1.1B | $973.3M | $756.9M | $684.8M | $689.6M | $590.6M | $539.5M | - | $424.1M |
| Capital Expenditures | - | $370.1M | $360.3M | $362.0M | $287.6M | $239.3M | $214.5M | $189.7M | - | $172.9M |
| Free Cash Flow | - | $778.0M | $612.9M | $395.0M | $397.2M | $450.4M | $376.0M | $349.8M | - | $251.2M |
| Share Buybacks | - | $211.3M | $11.8M | $308.6M | $55.8M | $14.6M | $51.2M | $81.5M | - | $97.5M |
| Dividends Paid | - | $219.9M | $200.6M | $183.5M | $163.2M | $133.8M | $123.0M | $112.5M | - | $93.2M |
| FCF Margin | - | 14.2% | 11.9% | 8.7% | 9.4% | 14.5% | 12.4% | 12.6% | - | 9.6% |